Related Experiment Video
Updated: May 19, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Deep vein thrombosis: current status and nanotechnology advances
Aniket S Wadajkar1,2, Sonia Santimano1,2, Maham Rahimi3
1Department of Bioengineering, The University of Texas at Arlington, Arlington, TX 76019, USA.
Biotechnology Advances
|September 4, 2012
Summary
Deep vein thrombosis (DVT) impacts millions globally, often leading to fatal pulmonary embolism (PE). Current diagnostics and treatments have limitations, driving research into advanced, non-invasive methods and nanomedicine for better DVT management.
Area of Science:
- Cardiovascular Medicine
- Diagnostic Imaging
- Nanomedicine
Background:
- Deep vein thrombosis (DVT) affects millions worldwide, with mortality often caused by pulmonary embolism (PE).
- Accurate diagnosis and effective treatment are crucial for managing DVT and preventing severe complications.
- Existing diagnostic and therapeutic methods have limitations, including invasiveness and significant side effects.
Purpose of the Study:
- To review the pathology of DVT and its associated complications like PE.
- To provide a comprehensive overview of current and emerging diagnostic and therapeutic modalities for DVT.
- To highlight the potential of advanced techniques, including nanomedicine, in DVT management.
Main Methods:
- Literature review of DVT pathology, diagnosis, and treatment.
- Detailed listing and description of available diagnostic tests (D-dimer, ultrasound, venography, MRI).
- Overview of current treatments (lifestyle changes, compression, anticoagulants, filters, surgery) and their limitations.
- Exploration of emerging technologies like enhanced ultrasound, molecular imaging, and nanomedicine.
Main Results:
- DVT diagnosis relies on clinical assessment and tests like D-dimer and imaging, with some methods requiring contrast agents.
- Current treatments for DVT carry risks such as incomplete clot resolution and hemorrhage.
- Novel approaches focusing on non-invasive diagnostics and targeted drug delivery via nanomedicine show promise for improved DVT care.
Conclusions:
- There is a critical need for improved, non-invasive diagnostic tools for DVT.
- Advanced therapeutic strategies, particularly those leveraging nanomedicine, offer potential for more effective and safer DVT treatment.
- Continued research into novel diagnostics and treatments is essential for reducing DVT morbidity and mortality.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...